Page last updated: 2024-08-17

nad and Metabolic Syndrome

nad has been researched along with Metabolic Syndrome in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (7.69)29.6817
2010's9 (69.23)24.3611
2020's3 (23.08)2.80

Authors

AuthorsStudies
Aflatounian, A; Bertoldo, MJ; Cochran, BJ; Edwards, MC; Gilchrist, RB; Ledger, WL; Paris, VR; Richani, D; Walters, KA; Wu, LE1
Boutant, M; Canto, C; Cercillieux, A; Giner, MP; Giroud-Gerbetant, J; Joffraud, M; Kulkarni, SS; Moco, S; Ratajczak, J; Sambeat, A; Sanchez-Garcia, JL; Valera-Alberni, M; Valsesia, A1
Chelvanambi, S; Frump, AL; Hester, JM; Lahm, T; Sharma, S1
Boriek, AM; Pardo, PS1
Kumari, B; Yadav, UCS1
Brunner, M; Sancar, G1
Yan, LJ1
Borradaile, NM; Chan, P; Hughes-Large, JM; Pang, DK; Robson, DL; Toma, J1
Buzadzic, B; Daiber, A; Jankovic, A; Korac, A; Korac, B; Otasevic, V; Stancic, A1
Hoth, JJ; Liu, T; McCall, CE; Vachharajani, VT; Wang, X; Yoza, BK1
Choi, HS; Chung, J; Han, J; Hwang, JH; Jang, C; Jo, EJ; Jo, YS; Kho, YL; Kim, DW; Kim, JM; Kim, YK; Kwak, TH; Kweon, GR; Kyung, T; Lee, I; Lee, SH; Park, JH; Park, MK; Shong, M; Yoo, SK1
Liang, Y; Vanhoutte, PM; Wang, Y; Xu, C1
Barbosa, MT; Capellini, V; Chini, EN; Escande, C; Gomes, AP; Nin, V; O'Neil, L; Price, NL; Sinclair, DA; White, TA1

Reviews

7 review(s) available for nad and Metabolic Syndrome

ArticleYear
SIRT1 Regulation in Ageing and Obesity.
    Mechanisms of ageing and development, 2020, Volume: 188

    Topics: Aging; Animals; Diabetes Mellitus, Type 2; DNA Damage; Exercise; Gene Expression Regulation; Humans; Hypoxia; Inflammation; Insulin Resistance; Metabolic Syndrome; Mice; NAD; Obesity; Oxidative Stress; Protein Domains; Protein Processing, Post-Translational; Risk; Sirtuin 1; Stress, Mechanical

2020
Adipokine Visfatin's Role in Pathogenesis of Diabesity and Related Metabolic Derangements.
    Current molecular medicine, 2018, Volume: 18, Issue:2

    Topics: Adipocytes; Adipokines; Adipose Tissue; Animals; Apoptosis; Biomarkers; Cytokines; Diabetes Mellitus; Disease Susceptibility; Glucose; Humans; Immunity; Metabolic Syndrome; Molecular Targeted Therapy; NAD; Nicotinamide Phosphoribosyltransferase; Signal Transduction

2018
Circadian clocks and energy metabolism.
    Cellular and molecular life sciences : CMLS, 2014, Volume: 71, Issue:14

    Topics: Adenosine Monophosphate; Adenosine Triphosphate; Circadian Clocks; Energy Metabolism; Gene Expression Regulation; Humans; Metabolic Syndrome; Models, Biological; NAD; Polymorphism, Genetic

2014
Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress.
    Journal of diabetes research, 2014, Volume: 2014

    Topics: Diabetes Mellitus, Type 2; Electron Transport; Glucose; Glycation End Products, Advanced; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycerophosphates; Humans; Hyperglycemia; Metabolic Syndrome; Mitochondria; NAD; Oxidative Stress; Protein Kinase C; Reactive Oxygen Species; Superoxides

2014
Redox implications in adipose tissue (dys)function--A new look at old acquaintances.
    Redox biology, 2015, Volume: 6

    Topics: Adipocytes; Adipogenesis; Adipose Tissue; Diabetes Mellitus, Type 2; Energy Metabolism; Humans; Hydrogen Peroxide; Insulin Resistance; Metabolic Syndrome; Mitochondria; NAD; NADPH Oxidases; Obesity; Oxidation-Reduction

2015
Sirtuins Link Inflammation and Metabolism.
    Journal of immunology research, 2016, Volume: 2016

    Topics: Adenosine Triphosphate; Alzheimer Disease; Animals; Cardiovascular Diseases; Energy Metabolism; Gene Expression Regulation; Homeostasis; Humans; Inflammation; Metabolic Syndrome; NAD; Oxidative Stress; Reactive Oxygen Species; Sepsis; Signal Transduction; Sirtuins

2016
SIRT1 in metabolic syndrome: where to target matters.
    Pharmacology & therapeutics, 2012, Volume: 136, Issue:3

    Topics: Aging; Animals; Cardiovascular Diseases; Exercise; Glucose; Humans; Lipid Metabolism; Metabolic Syndrome; Muscle, Skeletal; NAD; Organ Specificity; Protein Structure, Tertiary; Sirtuin 1

2012

Other Studies

6 other study(ies) available for nad and Metabolic Syndrome

ArticleYear
Declining muscle NAD
    Molecular metabolism, 2022, Volume: 65

    Topics: Animals; Dihydrotestosterone; Female; Humans; Hyperandrogenism; Insulin Resistance; Lipids; Metabolic Syndrome; Mice; Muscle, Skeletal; NAD; Nicotinamide Mononucleotide; Obesity; Polycystic Ovary Syndrome

2022
Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage.
    Nature communications, 2019, 09-20, Volume: 10, Issue:1

    Topics: Animals; Blood Glucose; Diet, High-Fat; Disease Models, Animal; DNA Damage; Gene Knockout Techniques; Genetic Predisposition to Disease; Glucose Intolerance; Hepatocytes; Insulin Resistance; Lipid Metabolism; Liver; Liver Diseases; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; NAD; Niacinamide; Phosphotransferases (Alcohol Group Acceptor); Protective Agents; Pyridinium Compounds

2019
Slide-Seq for Spatially Mapping Gene Expression. Metabolic Syndrome Exacerbates Group 2 Pulmonary Hypertension, and NAD Metabolism Is Influenced by Tissue Origin.
    American journal of respiratory cell and molecular biology, 2020, Volume: 62, Issue:1

    Topics: Gene Expression; Humans; Hypertension, Pulmonary; Metabolic Syndrome; NAD

2020
Niacin receptor activation improves human microvascular endothelial cell angiogenic function during lipotoxicity.
    Atherosclerosis, 2014, Volume: 237, Issue:2

    Topics: Animals; Aorta; Apoptosis; Cattle; Cell Death; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen; Drug Combinations; Endothelial Cells; Gene Expression Regulation; Humans; Immunohistochemistry; Laminin; Lipids; Metabolic Syndrome; Microcirculation; NAD; Niacin; Nicotinamide Mononucleotide; Obesity; Protein Binding; Proteoglycans; Pyrazoles; Receptors, G-Protein-Coupled; Receptors, Nicotinic; RNA Interference; RNA, Small Interfering; Serum Albumin

2014
Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice.
    Diabetes, 2009, Volume: 58, Issue:4

    Topics: Adenylate Kinase; Animals; Disease Models, Animal; Energy Metabolism; Metabolic Syndrome; Mice; Mice, Knockout; NAD; NAD(P)H Dehydrogenase (Quinone); NADPH Dehydrogenase; Naphthoquinones; Obesity; Oxidation-Reduction; Phenotype; Signal Transduction

2009
Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome.
    Diabetes, 2013, Volume: 62, Issue:4

    Topics: ADP-ribosyl Cyclase 1; Animals; Apigenin; Cell Line, Tumor; Gene Expression Regulation; Humans; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Structure; NAD; Obesity; Quercetin; Random Allocation; Sirtuin 1

2013